Germany Freight Transport Report

 Published On: Nov, 2013 |    No of Pages: 102 |  Published By: BMI Freight Transport | Format: PDF
Request Free Sample

Industry View
Following a year in which BMI believes saw the recovery resume, 2014 will signal further growth and
some of the freight modes return to their pre-downturn levels.
Total trade is projected to pick up with our Country Risk desk forecasting a y-o-y increase of 1.35% in 2014
following an estimated growth of 0.3% in 2013.
Road freight is to continue to dominate the sector and is projected to grow by 2% in 2014. The sector did
not manage to defy the downturn losing more than 11% of freight volumes over 2009 and 2010 before a
strong recovery begun in 2011.

Industry View 7
SWOT 9
Political 11
Economic 12
Business Environment 13
Industry Forecast 14
Pharmaceutical Market Forecast 14
Table: Germany Pharmaceutical Sales, Historical Data and Forecasts 15
Healthcare Market Forecast 16
Table: Germany Healthcare Expenditure Trends, Historical Data and Forecasts 17
Table: Germany Government Healthcare Expenditure Trends, Historical Data and Forecasts 17
Table: Germany Private Healthcare Expenditure Trends, Historical Data and Forecasts 18
Prescription Drug Market Forecast 19
Table: Retail Pharmaceutical Expenditure, 2003-10 (EURbn) 20
Table: Retail Pharmaceutical Expenditure, 2003-10 (Packages, ms) 20
Table: Retail Pharmaceutical Expenditure, 2003-10 (Average Price per Pack, EUR) 20
Table: Germany Prescription Drug Market Indicators, Historical Data and Forecasts 21
Patented Drug Market Forecast 22
Table: Germany Patented Drug Market Indicators, Historical Data and Forecasts 23
Generic Drug Market Forecast 24
Table: Germany Generics Drug Market Indicators, Historical Data and Forecasts 26
OTC Medicine Market Forecast 27
Table: Germany Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts 28
Pharmaceutical Trade 29
Table: Germany Pharmaceutical Trade Data And Forecasts (US$mn) 30
Table: Germany Pharmaceutical Trade Data And Forecasts (EURmn) 31
Other Healthcare Data 32
Key Risks To BMI's Forecast Scenario 32
Macroeconomic Forecasts 34
Economic Analysis 34
Table: Germany - Economic Activity 39
Industry Risk Reward Ratings 40
Western Europe Risk/Reward Ratings 40
Germany Risk/Reward Ratings 44
Rewards 44
Risks 45
Market Overview 46
Industry Trends And Developments 47
Epidemiology 47
Healthcare Sector 48
Health Insurance 48
Healthcare Sector Reforms 49
Research & Development 51
Biotechnology Sector 54
Table: Biotechnology Sector, 2008-09 55
Clinical Trials 57
Regulatory Development 58
Table: BfArM Drug Registration Activity, 2006-10 58
Intellectual Property Regime 60
2010 Healthcare Reform 61
Pricing Regime 62
Table: Price Build-Up In The German Pharmaceutical Market 63
Table: Selected AMNOG Drug Assessments 65
Reimbursement Regime 68
Table: Top 10 GKV Selling Drug Brands, 2009-2010 (EURmn) 69
Parallel Imports 72
Competitive Landscape 73
Table: Pharmaceutical Production, 1990-10 73
Table: Leading German Pharmaceutical Companies 75
Wholesale Sector 76
Table: Members of the Association of Pharmaceutical Wholesalers (PHAGRO), 2012 76
Retail Sector 79
Company Profile 85
Bayer HealthCare 85
Boehringer Ingelheim 90
STADA Arzneimittel 96
Grünenthal 101
Merck KGaA 103
GlaxoSmithKline (GSK) 108
Pfizer 111
Sanofi 114
Merck & Co 117
Demographic Forecast 119
Demographic Outlook 119
Table: Germany's Population By Age Group, 1990-2020 ('000) 120
Table: Germany's Population By Age Group, 1990-2020 (% of total) 121
Table: Germany's Key Population Ratios, 1990-2020 122
Table: Germany's Rural And Urban Population, 1990-2020 122
Glossary 123
Methodology 125
Pharmaceutical Expenditure Forecast Model 125
Healthcare Expenditure Forecast Model 125
Notes On Methodology 126
Risk/Reward Ratings Methodology 127
Ratings Overview 128
Table: Pharmaceutical Risk/Reward Ratings Indicators 128
Indicator Weightings 129

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.